Chopra’s dissent: The Tipline for 23 October 2018

FTC commissioner Rohit Chopra yesterday objected to his agency’s approval of the Linde/Praxair merger, criticising the agreed remedies for failing to protect competition. We also have a litigator of the week piece honouring a team at White & Case that convinced an appellate court to overturn a decision certifying a class of plaintiffs in a claim against Allergan.

Get unlimited access to all Global Competition Review content